About Wetlin Research Associates, Inc
Clinical Trials at Wetlin Research Associates, Inc
During the past decade, Wetlin Research Associates, Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on
average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Wetlin Research Associates, Inc" #1 sponsor was "Pfizer" with 4 trials, followed by "AstraZeneca" with 1 trials
sponsored, "Orexo AB" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Sunovion"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wetlin Research Associates, Inc"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Wetlin Research Associates, Inc
According to Clinical.Site data, the most researched conditions in "Wetlin Research Associates, Inc" are
"Cardiovascular Disease" (2 trials), "Low Back Pain" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Chronic Bronchitis" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Wetlin Research Associates, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Wetlin Research Associates, Inc
Most popular intervention types in "Wetlin Research Associates, Inc" are "Drug" (6 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Naproxen" (2 trials), "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Dapagliflozin" (1 trials) and "Ibuprofen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Wetlin Research Associates, Inc
The vast majority of trials in "Wetlin Research Associates, Inc" are
8 trials for "All" genders.
Clinical Trials Status at Wetlin Research Associates, Inc
Currently, there are NaN active trials in "Wetlin Research Associates, Inc".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Wetlin Research Associates, Inc,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Wetlin Research Associates, Inc, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".